Avalon Investment & Advisory’s Bio-Techne TECH Stock Holding History

Avalon Investment & Advisory’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	$721K	Sell	9,716 -1,594	-14%	-$123K	0.02%	227
2022 Q4	$937K	Buy	11,310 +1,578	+16%	+$125K	0.03%	207
2022 Q3	$691K	Sell	9,732 -268	-3%	-$23.2K	0.02%	217
2022 Q2	$867K	Sell	10,000 -2,060	-17%	-$193K	0.02%	207
2022 Q1	$1.31M	Sell	12,060 -184	-2%	-$19K	0.03%	190
2021 Q4	$1.58M	Sell	12,244 -1,652	-12%	-$203K	0.04%	184
2021 Q3	$1.68M	Buy	13,896 +212	+2%	+$25.8K	0.04%	202
2021 Q2	$1.54M	Sell	13,684 -12	-0.1%	-$1.26K	0.03%	214
2021 Q1	$1.31M	Buy	13,696 +580	+4%	+$52.9K	0.03%	219
2020 Q4	$1.04M	Buy	13,116 +2,444	+23%	+$177K	0.02%	241
2020 Q3	$661K	Buy	10,672 +6,116	+134%	+$398K	0.01%	244
2020 Q2	$301K	Buy	+4,556	New	+$273K	0.01%	266

Other funds holding TECH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Avalon Investment & Advisory's TECH Position: Q1 2023 in Review

Avalon Investment & Advisory reduced its Bio-Techne (TECH) stake by 14% in Q1 2023, selling an estimated $123K and leaving 9,716 shares worth $721K. The position accounts for 0.02% of the portfolio, ranked #227.

Avalon Investment & Advisory first reported a position in TECH in Q2 2020 and has held it in 12 quarters since. The position peaked at $1.68M in Q3 2021. 550 funds tracked by Wall St. Rank hold TECH as of Q1 2023.

Avalon Investment & Advisory held 9,716 shares of Bio-Techne worth $721K as of Q1 2023.
Avalon Investment & Advisory sold 1,594 Bio-Techne shares in Q1 2023, an estimated $123K.
Bio-Techne made up 0.02% of Avalon Investment & Advisory's portfolio in Q1 2023, its #227 holding.
Avalon Investment & Advisory first reported a position in Bio-Techne in Q2 2020 and has held it in 12 quarters since.
Avalon Investment & Advisory's Bio-Techne position peaked at $1.68M in Q3 2021.
550 funds tracked by Wall St. Rank held Bio-Techne as of Q1 2023.

Based on Avalon Investment & Advisory's 13F filing for Q1 2023, filed 15 May 2023.